Yahoo Web Search

Search results

    • iZafe Group's Quarterly Report January-March 2024

      StreetInsider· 13 hours ago

      The quarter's revenue consists of income related to the sale of the digital medication robot Dosell as well as sales of the medical technical aid Pilloxa. In conjunction with this launch, iZafe ...

    • BioInvent International AB: Interim Report January-March 2024

      Digital Journal· 3 days ago

      ...with MSD to evaluate BI-1910, the company's second anti-TNFR2 antibody in combination with KEYTRUDA® (pembrolizumab) (R)= Regulatory event FINANCIAL INFORMATION First quarter 2024 Net sales, SEK 5.9 (16.2) million Profit/loss after tax, SEK -77.9 (-73.7) million Profit/loss after tax per share...